已收盤 08-07 16:00:00 美东时间
+13.680
+4.70%
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
华盛资讯8月7日讯,MKS仪器公布2026财年Q2业绩,公司Q2营收12.48亿美元,同比增长28.3%,归母净利润1.75亿美元,同比增长182.3%。
08-07 03:53
华盛资讯8月6日讯,MKS仪器公布2026财年Q2业绩,公司Q2营收12.48亿美元,同比增长28.3%,归母净利润1.75亿美元,同比增长182.3%。
08-06 06:32
MKS (NASDAQ:MKSI) is looking for Q3 GAAP EPS of $2.42-$3.04 vs $2.31 analyst estimate..
08-06 04:39
Source: TradePulse | August 5, 2026 Market Overview Recent aggregate flow data reflects continued institutional participation across several key market segments, with aerospace and defense, industrials, healthcare, biotechnology, semiconductors, technology, real estate, precious metals, cybersecurit...
08-06 03:09
MKS (NASDAQ:MKSI) has outperformed the market over the past 5 years by 3.86% on an annualized basis producing an average annual return of 15.67%. Currently, MKS has a market capitalization of $21.32 billion. Buying $100 In MKSI: If an investor had bought $100 of MKSI stock 5 years ago, it would be w...
08-05 23:15
MKS Inc. announced that its Board of Directors has authorized a quarterly cash dividend of $0.25 per share, payable on September 3, 2026, to shareholders of record as of August 25, 2026. The company provides enabling technologies for semiconductor manufacturing, electronics, and specialty industrial applications, delivering solutions that improve process performance and optimize productivity. Future dividends are subject to board approval.
08-04 13:00
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
Cantor Fitzgerald analyst Matthew Prisco reiterates MKS (NASDAQ:MKSI) with a Overweight and maintains $600 price target.
08-03 20:35
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02